Business News

Glenmark introduces an ophthalmic solution for the treatment of glaucoma

Glenmark Pharmaceuticals Inc, USA on Wednesday said it launched Travoprost ophthalmic solution used in the treatment of glaucoma.

The introduction of Travoprost ophthalmic solution USP, 0.004 percent adds to the company’s portfolio of prescription eye products, said Glenmark Pharmaceuticals Executive Vice President, Jim Brown. Image source: Official website




Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button